Manifestaciones neuro-psiquiátricas en COVID-19

1 Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20: 533–34.

2 Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12: 15–22.

3 Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019; 12: 12.

4 Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–66.

5 Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014; 29: 301–06.

6 Hung EWC, Chim SSC, Chan PKS, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 2003: 49: 2108–09.

7 Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, Yuen KY. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004; 10: 342–44.

8 Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis 2005; 41: 1089–96.

9 Tsai LK, Hsieh ST, Chao CC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol 2004; 61: 1669–73.

10 Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med 2020; 46: 637–53.

11 Algahtani H, Subahi A, Shirah B. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med 2016; 2016: 3502683.

12 Arabi YM, Harthi A, Hussein J, et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 2015; 43: 495–501.

13 Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017; 13: 227–33.

14 Morfopoulou S, Brown JR, Davies EG, et al. Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med 2016; 375: 497–98.

15 Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004; 113: e73–76.

16 Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology 2016; 59: 163–69.

17 Goenka A, Michael BD, Ledger E, et al. Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. Clin Infect Dis 2014; 58: 775–84.

18 Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003; 28: 225–32.

19 Gu Y, Shimada T, Yasui Y, Tada Y, Kaku M, Okabe N. National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009–2010 influenza pandemic. PLoS One 2013; 8: e54786.

20 Kwon S, Kim S, Cho M, Seo H. Cho M Hyun, Seo H. Neurologic complications and outcomes of pandemic (H1N1) 2009 in Korean children. J Korean Med Sci 2012; 27: 402.

21 Khandaker G, Zurynski Y, Buttery J, et al. Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology 2012; 79: 1474–81.

22 Glaser CA, Winter K, DuBray K, et al. A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. Clin Infect Dis 2012; 55: 514–20.

23 Foley PB. Encephalitis lethargica and influenza. I. The role of the influenza virus in the influenza pandemic of 1918/1919. J Neural Transm (Vienna) 2009; 116: 143–50.

24 Tobi H, van den Berg PB, de Jong-van den Berg LTW. Small proportions: what to report for confidence intervals? Pharmacoepidemiol Drug Saf 2005; 14: 239–47.

25 Varatharaj A, Thomas N, Ellul M, et al. UK-wide surveillance of neurological and neuropsychiatric complications of COVID-19: the first 153 patients. SSRN 2020; published online May 22. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3601761 (preprint).

26 WHO. Coronavirus disease 2019 (COVID-19): situation report, 61. Geneva: World Health Organization, 2020.

27 WHO. Laboratory testing for coronavirus disease 2019 (2019-nCoV) in suspected human cases. Geneva: World Health Organization, 2020.

28 Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355: 1053–59.

29 Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010; 138: 783–800.

30 Mehta R, Soares CN, Medialdea-Carrera R, et al. The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: a case series. PLoS Negl Trop Dis 2018; 12: e0006212.

31 Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/ encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 2020; 94: 55–58.

32 Sohal S, Mossammat M. COVID-19 presenting with seizures. IDCases 2020; 20: e00782.

33 Wong PF, Craik S, Newman P, et al. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond) 2020; published online May 5. https://doi.org.10.7861/clinmed.2020-0182.

34 Dugue R, Cay-Martínez KC, Thakur KT, et al. Neurologic manifestations in an infant with COVID-19. Neurology 2020; published online April 23. https://doi.org.10.1212/ WNL.0000000000009653.

35 Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268–70.

36 Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; published online April 10. https://doi.org.10.1001/jamaneurol.2020.1127.

37 Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020; published online March 31. https://doi.org.10.1148/radiol.2020201187.

38 Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 2020; 92: 699–702.

39 Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: underestimated damage to nervous system. Travel Med Infect Dis 2020; published online March 24. DOI:10.1016/j.tmaid.2020.101642.

40 Zanin L, Saraceno G, Panciani PP, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020; published online May 4. https://doi.org.10.1007/s00701-020-04374-x.

41 Zhang T, Rodricks MB, Hirsh E. COVID-19-associated acute disseminated encephalomyelitis: a case report. medRxiv 2020. https://doi.org.2020.04.16.20068148 (preprint).

42 Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv 2020. https://doi.org.2020.03.16.20035105 (preprint).

43 Camdessanche J-P, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020; 176: 516–18.

44 Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 2020; published online April 17. DOI:10.1056/NEJMc2009191.

45 Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020; 19: 383–84.

46 Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 2020; published online April 17. https://doi.org.10.1212/ WNL.0000000000009619.

47 Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 2020; published online May 1. https://doi.org.10.1212/ WNL.0000000000009700.

48 Escalada Pellitero S, Garriga Ferrer-Bergua L. Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection. Neurologia 2020; 35: 271–71.

49 Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis 2020; published online March 20. https://doi.org.10.3201/eid2607.200445.

50 Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; published online April 6. https://doi.org.10.1007/s00405-020- 05965-1.

51 Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun 2020; published online April 28. https://doi.org.10.1016/j.bbi.2020.04.077.

52 Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 2020; published online April 30. DOI:jnnp-2020-323586.

53 Li Y, Wang M, Zhou Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. 2020. https://media.tghn.org/medialibrary/2020/06/Li_2020_Preprint_ Acute_cerebrovascular_disease_COVID19.pdf (preprint).

54 Morassi M, Bagatto D, Cobelli M, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol 2020; published online May 20. https://doi.org.10.1007/s00415-020-09885-2.

55 Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382: e60.

56 Al Saiegh F, Ghosh R, Leibold A, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry 2020; published online April 30. https://doi.org.jnnp-2020-323522.

57 Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults—Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012; 64: 347–73.